Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.

Viatris

Status and phase: Completed; Phase 4

Conditions: Back Pain

Treatments: Drug: Tramadol Hydrochloride 50mg; Drug: Celebrex 200mg

Study type: Interventional

Funder types: Industry

Identifiers

NCT00290901

A3191165

Details and patient eligibility

About

This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• The subject presents with duration of chronic low back pain of > 3 months requiring regular use of analgesics (> 4 days/week), except for acetaminophen which cannot have been the sole analgesic used.

Exclusion criteria

• The subject has chronic low back pain, which is neurologic in etiology (i.e., radiculopathy, neuropathy, myelopathy)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind